Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WHO To Help Fast-Track Improvements In China Products Regulation (China)

This article was originally published in PharmAsia News

Executive Summary

The World Health Organization is working to fast-track improvements of food and products regulation in China, whose exports have become a source of safety concern in recent months. "The Food and Safety department of the World Health Organization in Geneva has been working with the government of China to streamline their regulation of food and products," WHO Director-General Dr. Margaret Chan said. Chan announced a special experts meeting in Beijing scheduled for mid-September. "The government of China is committed to improving their system," she added. In an effort to regain consumer confidence, a Cabinet-level panel announced last week the launch of a nationwide safety campaign focused on food and drugs, as well as increased monitoring of exports. (Click here for more - May Require Paid Subscription
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066472

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel